Literature DB >> 16252197

The value of serum zinc, copper, ceruloplasmin levels in patients with gastrointestinal tract cancers.

Alper Boz1, Osman Evliyaoğlu, Mehmet Yildirim, Nazif Erkan, Baysal Karaca.   

Abstract

BACKGROUND/AIMS: Gastrointestinal cancers are frequent diseases of particular importance for surgeons with regard to their management and follow-up. Neoplastic diseases activate antioxidant defense systems. As a result, concentrations of redoxal enzymes and their co-factor elements appear to change. The levels of zinc (Zn), copper (Cu) and ceruloplasmin have been found to be critical parameters. In addition, it seems to be important to consider the Cu/Zn ratio in such cases. In this study, changes in the levels of Cu, Zn and ceruloplasmin in patients with gastrointestinal system cancers was evaluated, and the proportion of Cu to Zn (Cu/Zn) is discussed.
METHODS: In this clinical trial, levels of Cu and Zn were defined with calorimetric methods and ceruloplasmin levels were measured with immunohistochemical methods in a control group of 20 healthy individuals and in 25 patients who underwent surgery for gastrointestinal system cancer. The blood samples were taken preoperatively in gastrointestinal system cancer patients.
RESULTS: This study has shown that while the decrease in Zn levels and the increase in ceruloplasmin levels in patients with gastrointestinal system cancers were found to be significant (p<0. 001, p=0. 014) when compared to the control group, the increase in the level of Cu was also found to be significant (p=0. 019). In the patient group, the correlations between serum Cu and serum ceruloplasmin proved to be significant (r=991, p<0. 001). The Cu/Zn ratio, when compared with Zn, ceruloplasmin and Cu, showed significant results (r= 0. 562, r= 0. 500, r=0. 506, p<0. 001).
CONCLUSIONS: This study shows that serum Cu, Zn and ceruloplasmin levels show changes in gastrointestinal system cancers, but further research is needed to demonstrate the importance and significance of these parameters and their relation with other contributing neoplastic factors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16252197

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  7 in total

1.  Time course of pulmonary inflammation and trace element biodistribution during and after sub-acute inhalation exposure to copper oxide nanoparticles in a murine model.

Authors:  Sudartip Areecheewakul; Andrea Adamcakova-Dodd; Ezazul Haque; Xuefang Jing; David K Meyerholz; Patrick T O'Shaughnessy; Peter S Thorne; Aliasger K Salem
Journal:  Part Fibre Toxicol       Date:  2022-06-13       Impact factor: 9.112

2.  Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.

Authors:  Adeboye O Osunkoya; Qiqin Yin-Goen; John H Phan; Richard A Moffitt; Todd H Stokes; May D Wang; Andrew N Young
Journal:  Hum Pathol       Date:  2009-08-19       Impact factor: 3.466

Review 3.  Zinc dysregulation in cancers and its potential as a therapeutic target.

Authors:  Jie Wang; Huanhuan Zhao; Zhelong Xu; Xinxin Cheng
Journal:  Cancer Biol Med       Date:  2020-08-15       Impact factor: 4.248

4.  Five Serum Trace Elements Associated with Risk of Cardia and Noncardia Gastric Cancer in a Matched Case-Control Study.

Authors:  Yulan Lin; Chuancheng Wu; Wei Yan; Saixiong Guo; Baoying Liu
Journal:  Cancer Manag Res       Date:  2020-06-10       Impact factor: 3.989

Review 5.  Copper metabolism as a unique vulnerability in cancer.

Authors:  Vinit C Shanbhag; Nikita Gudekar; Kimberly Jasmer; Christos Papageorgiou; Kamal Singh; Michael J Petris
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2020-10-20       Impact factor: 4.739

6.  Serum and tissue zinc in epithelial malignancies: a meta-analysis.

Authors:  Jaromir Gumulec; Michal Masarik; Vojtech Adam; Tomas Eckschlager; Ivo Provaznik; Rene Kizek
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

7.  In-Depth Mapping of the Urinary N-Glycoproteome: Distinct Signatures of ccRCC-related Progression.

Authors:  Lucia Santorelli; Giulia Capitoli; Clizia Chinello; Isabella Piga; Francesca Clerici; Vanna Denti; Andrew Smith; Angelica Grasso; Francesca Raimondo; Marco Grasso; Fulvio Magni
Journal:  Cancers (Basel)       Date:  2020-01-18       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.